Patent application number | Description | Published |
20130184478 | CRYSTALLINE SOLVATE AND NON-SOLVATED FORMS OF 6,6'-[[3,3',5,5'-TETRAKIS(1,1-DIMETHYLETHYL)-[1,1'-BIPHENYL]-2,2'-DIYL]BI- S(OXY)]BIS-DIBENZO [D,F] [1,3,2]-DIOXAPHOSPHEPINE - The present invention relates to a crystalline non-solvated form of 6,6′-[[3,3′,5,5′-tetrakis(1,1-dimethylethyl)-[1,1′-biphenyl]-2,2′-diyl]bis(oxy)]bis-dibenzo[d,f][1,3,2]-dioxaphosphepine (compound I) and toluene-solvates and acetone-solvates thereof. | 07-18-2013 |
20140205641 | Co-Crystals of Cyprodinil and Dithianon - The present invention relates to co-crystals of cyprodinil and dithianon as defined in the description, processes for preparing these co-crystals and also to compositions comprising at least such co-crystals. The invention also relates to the use of such co-crystals or compositions for combating harmful fungi. | 07-24-2014 |
20150018207 | METHOD FOR PRODUCING AN AQUEOUS SUSPENSION CONCENTRATE FORMULATION OF A PYRIPYROPENE INSECTICIDE - The present invention relates to a method for producing an aqueous suspension concentrate formulation and novel suspension concentrate formulations of the compound of formula I. | 01-15-2015 |
20150065347 | CO-CRYSTALS OF DICAMBA AND A CO-CRYSTAL FORMER B - Co-crystals comprising
| 03-05-2015 |
20150099631 | CRYSTALLINE FORM A OF 1,5-DIMETHYL-6-THIOXO-3-(2,2,7-TRIFLUORO-3-OXO-4-(PROP-2-YNYL)-3,4-DIHYDR- O-2H-BENZO[B][1,4]OXAZIN-6-YL)-1,3,5-TRIAZINANE-2,4-DIONE - The present invention relates to a novel crystalline form A of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione. The invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione. | 04-09-2015 |
20150126520 | MULTICOMPONENT CRYSTALS COMPRISING IMATINIB MESILATE AND SELECTED CO-CRYSTAL FORMERS - Novel solid forms of imatinib mesilate comprising as active ingredient 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]-benzamide methanesulfonic acid salt and as co-crystal former benzoic acid, fumaric acid or succinic acid are described. The said multi-component crystalline forms possess improved physical and biological properties with respect to the crystalline forms of the active pharmaceutical ingredient previously known. | 05-07-2015 |
20150133463 | MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED CO-CRYSTAL FORMERS - Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(−)-menthol. | 05-14-2015 |
20150141253 | CRYSTALLINE FORM B OF 1,5-DIMETHYL-6-THIOXO-3-(2,2,7-TRIFLUORO-3-OXO-4-(PROP-2-YNYL)-3,4-DIHYDR- O-2H-BENZO[B][1,4]OXAZIN-6-YL)-1,3,5-TRIAZINANE-2,4-DIONE - The present invention relates to a novel crystalline form B of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione The invention also relates to a process for the production of this crystalline form and formulations for plant protection which contains the novel crystalline form of 1,5-dimethyl-6-thioxo-3-(2,2,7-trifluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-1,3,5-triazinane-2,4-dione. | 05-21-2015 |
20150175544 | MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING DEFERASIROX AND ISONICOTINAMIDE AND A PROCESS FOR THE PREPARATION THEREOF - The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN: Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same. | 06-25-2015 |
20150246901 | MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING NILOTINIB AND SELECTED CO-CRYSTAL FORMERS - The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial. | 09-03-2015 |
Patent application number | Description | Published |
20080214702 | Biodegradable Aliphatic-Aromatic Polyesters - Biodegradable aliphatic/aromatic copolyester comprising 50 to 60 mol % of an aromatic dicarboxylic acid and 40 to 50 mol % of an aliphatic acid, at least 90% of which is a long-chain dicarboxylic acid (LCDA) of natural origin selected from azelaic acid, sebacic acid, brassylic acid or mixtures thereof; and a diol component. | 09-04-2008 |
20080214724 | PROCESS FOR FORMING BIODEGRADEABLE POLYESTERS BY REACTIVE EXTRUSION - Described is a process for increasing the molecular weight of a composition of one or more biodegradable aliphatic and/or aliphatic-aromatic thermoplastic polyesters of the dicarboxylic acid/diol type, comprising the reactive extrusion of said polyesters with organic peroxides; and a composition obtained by the process. | 09-04-2008 |
20080245995 | Improved Process for the Production of Derivatives of Saturated Carboxylic Acids - A process for the production of carboxylic acids and their derivatives comprising the steps of: (c) reacting a derivative of an unsaturated fatty acid with an oxidizing compound in the presence of a catalyst capable of catalysing the reaction of oxidation of the double olefinic bond of the derivative of the unsaturated fatty acid so as to obtain as intermediate product of reaction a vicinal diol; and (d) reacting said intermediate compound with oxygen, or a compound containing oxygen, in the presence of a catalyst capable of catalysing the reaction of oxidation of the hydroxyl groups of the vicinal diol to carboxylic groups, characterized in that both of the steps (a) and (b) are carried out in the absence of added organic solvent and in that the water/diol ratio in the reaction of step (b) is less than 1:1. | 10-09-2008 |
20090005472 | Biodegradable Aliphatic-Aromatic Copolyester - Biodegradable aliphatic/aromatic copolyester comprising: A) an acid component comprising repeating units of: 1) 53 to 54 mol % of an aromatic carboxylic acid; 2) 47 to 36 mol % of an aliphatic acid at least 50% of which is azelaic acid ; B) a diol component selected from the group consisting of C | 01-01-2009 |
20100311995 | PROCESS FOR THE CATALYTIC CLEAVAGE OF VEGETABLE OILS - Process for the production of saturated monocarboxylic acids and triglycerides of saturated carboxylic acids having more than one acid functionstarting from non-modified vegetable oils containing triglycerides of unsaturated fattyacids, comprising the oxidative cleavage of the unsaturated fatty acids. | 12-09-2010 |
20120219740 | BIODEGRADABLE ALIPHATIC-AROMATIC POLYESTERS - Biodegradable aliphatic/aromatic copolyester comprising 50 to 60 mol % of an aromatic dicarboxylic acid and 40 to 50 mol % of an aliphatic acid, at least 90% of which is a long-chain dicarboxylic acid (LCDA) of natural origin selected from azelaic acid, sebacic acid, brassylic acid or mixtures thereof; and a diol component. | 08-30-2012 |
20120220680 | BIODEGRADABLE ALIPHATIC-AROMATIC POLYESTER - The present invention relates to biodegradable aliphatic-aromatic polyesters obtained from aliphatic dicarboxylic acids, polyfunctional aromatic acids and diols, wherein the polyfunctional aromatic acids are constituted by mixtures of acids of renewable and synthetic origin. | 08-30-2012 |
20120220687 | BIODEGRADABLE ALIPHATIC-AROMATIC COPOLYESTER - Biodegradable aliphatic/aromatic copolyester comprising 49 to 66 mol % of an aromatic polyfunctional acid; 51 to 34 mol % of an aliphatic acid, at least 70% of which is sebacic acid; and butandiol; and blends containing such copolyester. | 08-30-2012 |
20120220698 | BIODEGRADABLE ALIPHATIC-AROMATIC POLYESTER - Biodegradable aliphatic/aromatic copolyester comprising: A) an acid component comprising repeating units of: 1) 49 to 63 mol % of an aromatic carboxylic acid; 2) 51 to 37 mol % of an carboxylic acid, at least 50% of which is brassylic acid; B) a diol component; said copolyester being disintegrated according to the Standard ISO 20200 in 90 days. | 08-30-2012 |
20120225230 | BIODEGRADABLE ALIPHATIC-AROMATIC COPOLYESTER - Biodegradable aliphatic/aromatic copolyester comprising: A) an acid component comprising repeating units of: 1) 53 to 54 mol % of an aromatic carboxylic acid; 2) 47 to 36 mol % of an aliphatic acid at least 50% of which is azelaic acid; B) a diol component selected from the group consisting of C | 09-06-2012 |
20120226060 | PROCESS FOR THE CATALYTIC CLEAVAGE OF VEGETABLE OILS - Process for the production of saturated monocarboxylic acids and triglycerides of saturated carboxylic acids having more than one acid function starting from non-modified vegetable oils containing triglycerides of unsaturated fatty acids, comprising the oxidative cleavage of the unsaturated fatty acids. | 09-06-2012 |
20120245259 | TERNARY MIXTURE OF BIODEGRADABLE POLYESTERS AND PRODUCTS OBTAINED THEREFROM - The invention relates to a mixture of biodegradable polyesters comprising: (A) a polyhydroxy acid of the poly-ε-caprolactone type and its copolymers, (B) aliphatic polyester, and (C) a polymer of polylactic acid, in which the concentration of (A) varies with respect to (A+B) in the range between 40 and 70% by weight, and the concentration of (C) with respects to (A+B+C) lies between 2 and 30%. | 09-27-2012 |
20130071588 | ALIPHATIC-AROMATIC COPOLYESTERS AND THEIR MIXTURES - This invention relates to an aliphatic-aromatic copolyester characterised in that it has appreciable workability properties even when mixed with other polymers, appreciable toughness and high values for ultimate tensile strength and elastic modulus. This invention also relates to mixtures of the said copolyester with other polymers. | 03-21-2013 |
20130281560 | POLYESTER COMPOSITION - This invention relates to a polymer composition comprising at least two polyesters having improved mechanical properties, in particular a good balance between ultimate tensile strength, elastic modulus and elongation on failure. This composition is particularly suitable for the production of manufactured articles such as for example films, moulded objects, thermoformed objects or expanded articles. | 10-24-2013 |
20150079867 | POLYESTERS COMPRISING 2-METHYLGLUTARIC ACID, PROCESS FOR PRODUCTION OF THE SAID POLYESTERS AND PRODUCTS OBTAINED THEREWITH - This invention relates to a polyester characterised by noteworthy workability properties even when mixed with other polymers and being capable of being converted into products such as for example films, fibres, non-woven fabrics, sheets, moulded, thermoformed, blow-moulded and expanded articles, characterised by great toughness and high elongation at failure values. This invention also relates to processes for production of the said polyesters. | 03-19-2015 |
Patent application number | Description | Published |
20120238627 | N-ACETYL-L-CYSTEINE FOR THE TREATMENT OF ENDOMETRIOSIS - The invention relates to a new prescription of NAC in the treatment of endometriosis and of indications associated with endometriosis, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in the treatment of endometriosis is proposed. In one embodiment of the present invention the prescribed treatment regimen may be used e.g. in order to control the frequency and the intensity of pain symptoms (dysmenorrhea, dyspareunia and acyclic chronic pelvic pain), to reduce the size of endometriotic lesions eventually up to their disappearance, to reduce recurrences after surgery and/or to improve fertility. Side effects of this treatment are virtually absent and, in particular, this treatment does not hinder pregnancy. | 09-20-2012 |
20140030307 | NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE - A combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin, and a medical product or pharmaceutical composition comprising such combination, useful for the treatment of a variety of diseases and conditions is described. The combination of N-acetyl-L-cysteine, selenium in the form of selenomethionine and melatonin is also useful for cosmetic treatment of skin and as an antibacterial agent. | 01-30-2014 |
20150283103 | N-ACETYL-L-CYSTEINE FOR USE IN IN VITRO FERTILIZATION - The invention relates to a new use of NAC in IVF, in a human or mammalian animal patient. In addition an effective dose regimen of NAC in IVF is proposed. | 10-08-2015 |
Patent application number | Description | Published |
20090019134 | Remote Access System and Method for Enabling a User to Remotely Access Terminal Equipment from a Subscriber Terminal - A method for enabling a subscriber terminal to remotely access terminal equipment, the terminal equipment storing identification data of the subscriber terminal, and the subscriber terminal being subscribed to a communication network and to a remote access service, wherein the method includes: receiving a request for authentication from the terminal equipment, the request for authentication including identification data of the subscriber terminal; receiving a request for access to the terminal equipment from the subscriber terminal; authenticating the subscriber terminal based on information from the communications network; forwarding the request for authentication from the terminal equipment to the subscriber terminal upon authenticating the subscriber terminal, the subscriber terminal processing the request for authentication to authenticate the terminal equipment; receiving an authentication notification from the subscriber terminal; forwarding the authentication notification from the subscriber terminal to the terminal equipment, the terminal equipment processing the authentication notification to authenticate said subscriber terminal; receiving an authentication notification from the terminal equipment; and enabling the subscriber terminal to remotely access the terminal equipment upon receiving the authentication notification from the terminal equipment. | 01-15-2009 |
20100142692 | Method and system for providing teleassistance services based on software agents executing workflows - A system for performing a teleassistance service, for example, in the medical field, comprising a central system for controlling and managing the service, a local system for performing the service, and a telecommunication network adapted to communicate the central system with the local system, wherein the local system includes at least one sensor adapted to perform measures of at least one biomedical parameter on a user and a terminal adapted to communicate with the sensor for receiving information related to measure results and adapted to transmit said information to the central system through the telecommunications network, and wherein at least one between the terminal and the central system includes a software agent provided with a process engine for executing workflows, said agent being adapted to interact with the sensor when executing workflows. | 06-10-2010 |
20100293263 | METHOD AND SYSTEM FOR MANAGING A NETWORK OF DISTRIBUTED ENTITIES - System architecture for managing a network of distributed entities, including a central server and a plurality of mobile terminals connected with the server. Terminals can communicate and exchange information with the server, but also among each other. Each mobile terminal is adapted to intercept the proximity of network entities having potentially a limited processing capability: in a preferred embodiment of the present invention, the entities are RFID Smart Tags, but other kinds of proximity communication protocols could be used instead (e.g. ZIGBee, Bluetooth). A central repository is maintained by the server where all the information collected by the mobile terminals is stored and is made available to the plurality of mobile terminals. The network entities must be capable of transmitting information to the mobile terminals when they are within a predetermined range. Each entity (e.g. an RFID Tag) can be coupled to any physical object and provide information about such object or the category to which the object belongs. According to a preferred embodiment of the present invention the entities are also adapted to transmit a workflow or a sequence of instructions to mobile terminals. The mobile terminals include a Task Engine for interpreting and executing such workflow received by the entities. In a preferred embodiment of the present invention the mobile terminals are provided with a positioning system to be able to communicate the location of the detected entities to the server. | 11-18-2010 |